DNA Based Vaccine Expressing SARS-CoV-2 Spike-CD40L Fusion Protein Confers Protection Against Challenge in a Syrian Hamster ModelLevi Tamming, Xuguang Li|Frontiers in Immunology|2022Cited by 20
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infectionAbenaya Muralidharan, Xuguang Li|Scientific Reports|2018Cited by 11
Impurity Removal Leading to High-Performance CoSb<sub>3</sub>-Based Skutterudites with Synergistic Carrier Concentration Optimization and Thermal Conductivity ReductionXuguang Li, Zhi‐Gang Chen, Shuangming Li et al.|ACS Applied Materials & Interfaces|2021Cited by 11
Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineagesCaroline Gravel, Xuguang Li|iScience|2021Cited by 10
Single Immunization of a Vaccine Vectored by a Novel Recombinant Vaccinia Virus Affords Effective Protection Against Respiratory Syncytial Virus Infection in Cotton RatsMarsha S. Russell, Xuguang Li|Frontiers in Immunology|2021Cited by 9